ctag

At intermediate stage you can adjust positioning and angulation, while allowing continuous blood flow throughout the procedure.

The TAG® Conformable Device combines a durable, proven stent graft with a delivery system that offers controlled, staged deployment.

At the intermediate deployment phase, the stent graft is not at full diameter, allowing for continuous blood flow through the aorta. This promotes hemodynamic stability throughout the procedure, which minimizes “windsocking.” It also reduces the need for aggressive blood pressure management or use of rapid pacing.  

Hemodynamic Flow Animation 

Demonstrates the continuous blood flow throughout deployment of the stent graft 

    The stabler the hemodynamics, the better it is for the patient.

    Robin H. Heijmen, M.D., Ph.D.

    Related to this product 

    IFU Consult instructions

    Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly

    INDICATIONS FOR USE IN EUROPE: The GORE® TAG® Conformable Thoracic Stent Graft is indicated for endovascular repair of all lesions of the descending thoracic aorta, including isolated lesions, such as aneurysm and traumatic transection, and Type B dissections.

    CONTRAINDICATIONS: The GORE® TAG® Conformable Thoracic Stent Graft is contraindicated in:

    • Patients with known sensitivities or allergies to the device materials
    • Patients with a systemic infection who may be at risk of endovascular graft infection 
    Product may not be available in all countries. Please check with your Gore representative for availability. 
    25AR2050-EN01